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SUMMARY Prostaglandin J2 (PGJ2) was found to suppress dramatically Sendai virus replication in African green monkey kidney cells in culture. PGJ2 was not toxic at the active dose to uninfected cells and did not significantly inhibit macromolecular synthesis, but it specifically stimulated the synthesis of a potypeptide of 74000 tool. wt. In Sendai virusinfected cells, PGJ2 partially inhibited virus protein synthesis and caused an alteration in the mobility of the virus glycoprotein HN in SDS-PAGE, corresponding to a decrease of about 4000 in its mol. wt. We propose that the PGJ2-induced alteration in the molecular structure of the HN protein prevents the insertion of this protein into the cell membrane thereby blocking virus maturation. The e,/~-unsaturated carbonyl group in the cyclopentane ring of the PGJ2 molecule may be necessary for antiviral activity.
Prostaglandins (PGs) have been shown to be involved in the regulation of many physiological phenomena, including cell growth and differentiation (Santoro & Jaffe, 1987) , immune function (Goodwin & Webb, 1980) and interferon action (Pottathil et al., 1980) .
We have previously demonstrated that PGs of the A series are potent inhibitors of virus replication in three different systems: Sendai virus in African green monkey kidney (AGMK) cells (Santoro et al., 1980 (Santoro et al., , 1981 and vaccinia virus and vesicular stomatitis virus in mouse L fibroblasts (Santoro et al., 1982a (Santoro et al., , 1983 Benavente et at., 1984) . The antiviral action was found to be specific for PGs of the A series (both PGA1 and PGA2), whereas PGs of the B, E and F series, prostacyclin, 6-keto PGFI~ and thromboxane B2 were inactive (Santoro et al., 1980) . PGAs have also been shown to suppress encephalomyocarditis virus replication in mouse L cells (Ankel et al., 1985) .
In the present report we describe the effect of prostaglandin J2, a dehydration product of PGD2 in aqueous solution (9-deoxy-A9-PGD~) (Fukushima et al., 1982b) , on the production of Sendai virus by an AGMK cell line (37RC) in culture.
The establishment and culture of 37RC cells have been previously described in detail (Santoro et al., 1981) . Confluent monolayers of 37RC cells were infected with egg-grown Sendai virus [10 haemagglutinating units (HAU)/10 s cells] and, 1 h after infection, virus inocula were removed and culture medium containing PGJ2 or control diluent was added. Sendai virus production was determined by measuring both the HAU present in the medium and haemadsorption (HAD) by infected monolayers of cells, as previously described (Santoro et al., 1981) . For HAD measurements, human O Rh + erythrocytes were used. After incubation at 4 °C for 60 min the monolayers were extensively washed and after cell lysis occurred the number of erythrocytes absorbed was quantified by haemoglobin (Hb) determination according to the technique of Crosby & Furth (1956) . PGJ2 did not interfere with either the haemagglutination (HA) or the HAD test. Preincubation of the virus with PGJ2 (from 1 to 10 gg/ml) or PGJ2 administration (4 gg/ml) at the time of testing did not alter HA; treatment of Sendai virus-infected AGMK (Santoro et al., 1980) . One h p.i., virus inocula were removed and culture medium containing PGJ 2 (O) or diluent control (0) was added. PGJ2 was stored as 100% ethanolic stock solution (1 mg/ml) and control medium contained the same concentration of absolute ethanol (0.02 %); this had no effect on virus replication. (a) Sendai virus production (HAU/2 x 105 cells/ml) was determined at different times p.i. (b) dose-response curve. Data are expressed as mean + s.t~. of at least duplicate samples. monolayers with PGJz (4 gg/ml)just before and/or during the HAD test had no effect on HAD (control, 99-6 _+ 0.1; PGJ2, 96.3 + 3-8 ~tg Hb/2 × 105 cells). Fig. 1 (a) shows the effect of PGJ 2 treatment (4 ~g/ml) on Sendai virus production (HAU/ml) at different times after infection (p.i.). PGJ2 was administered only once, after the l h infection period, and culture medium was not changed in the following 72 h. PGJ2 was found to suppress Sendai virus production by more than 93 % at 24, 48 and 72 h p.i. In four separate experiments PGJ2 at 4 ~tg/ml was able to inhibit Sendai virus production by 93 to 100%, without being toxic to uninfected AGMK cells. PGJ2 did not prevent the Sendai virus-induced cytopathic effect, but generally delayed it for 10 to 12 h.
A PGJ2 dose-response curve is shown in Fig. 1 (b). PGJ2 was added 1 h after virus infection and Sendai virus titres were determined 48 h p.i. PGJ2 antiviral activity was found to be dosedependent; 50% inhibition of virus replication was obtained with doses of 1 ~tg/ml and 4 ~tg/ml was the most active dose that was non-toxic to AGMK cells. Similar dose-response curves have been previously described for PGA1 and PGA2 antiviral activity in the same system (Santoro et al., 1981) .
Unlike interferon, which inhibits virus replication only if the host cell has been treated prior to virus infection, pretreatment of the host cell was not required for the PGJ2 antiviral effect to occur. Moreover, PGJ2 was not acting by inactivating the virus itself or by inhibiting virus adsorption by the cells, since neither the pretreatment of Sendai virus with PG J 2 (4 ~tg/ml) for 15 min before infection, nor the presence of PGJ2 (4 gg/ml) during the 1 h infection period, had any effect on virus replication in AGMK cells (at 24 h p.i., the HA titres were: control, 16-0 _+ 2.0; PGJ2 virus pretreatment, 16.0 _+ 0.0; PGJ2 during adsorption, 16-0 _+ 2.0 HAU/ml; HAD measurements at 24 h were: control, 99.8 _+ 0.1; PGJ2 virus pretreatment, 94.9 + 4.9; PGJ2 during adsorption, 96-3 _+ 3.8 ~tg Hb/2 × 105 cells).
At the dose at which more than 93 % of virus production was inhibited, treatment with PGJ2 of uninfected AGMK cells did not produce any toxic effect, as determined by either microscopic examination or by vital dye exclusion.
The effect of PGJ2 treatment on macromolecular synthesis in uninfected as well as infected AGMK cells is shown in Fig. 2 (Santoro et al., 1982a) . Briefly, cells were washed three times with phosphate-buffered saline and 0.4 ml 5~ TCA was added to each culture. After 1 h, radioactivity in acid-soluble material was counted. Acid-insoluble radioactivity was measured after washing the TCA precipitates with ethanol three times, drying under an infrared lamp and dissolving the samples in 0.4 ml of a solution containing 0-1 M-NaOH, 0.5~ SDS. (Fig. 2a) .
In Sendal virus-infected cells PGJ2 treatment caused changes in D N A and R N A synthesis and uptake of precursors similar to the alterations described in uninfected cells (Fig. 2b) The pattern of host and virus protein synthesis was analysed after labelling with [3SS]methionine by separation in SDS-polyacrylamide gels and autoradiography. PGJ2 did not alter the pattern of protein synthesis in uninfected cells, but specifically stimulated the synthesis of a polypeptide of 74000 mol. wt. (PJp74).
In Sendal virus-infected cells, PGJ2 produced a slight general inhibition of virus protein synthesis; however, the synthesis of the glycoprotein H N was by far the most potently inhibited of all virus proteins. More interestingly, slightly altered mobility, equivalent to a mol. wt. difference of approx. 4000, of the HN protein was observed in [35S]methionine-labelled cell extracts from PGJe-treated cells (Fig. 3a) . This was also demonstrated by the densitometric analysis shown in Fig. 3 (b) . Preliminary experiments suggest that the slight reduction in mol. wt. 1 and 2) or infected (lanes 3 and 4) cells, (2,4) treated with PGJ2 (4 gg/ml) or (1,3) control diluent. PGJ2 treatment was started after the 1 h adsorption period. Cells were labelled soon after infection with 10 gCi/106 cells [3sS]methionine, in methionine-deprived medium, supplemented with 10~ dialysed FCS. After 24 h, the radioactivity incorporated was determined (Santoro et al., 1982a) and samples were analysed by SDS PAGE in a vertical slab gel apparatus (3~ stacking gel, 7.5~ resolving gel), using the buffer system described by Laemmli (1970) . Gels were washed, fixed in 10~ acetic acid, 10~ TCA and 30~. methanol, dried under vacuum and autoradiographed using DuPont Cronex films. Mol. wt. of polypeptides were calculated using the following 1 ,C.methylate d mixture ( of the H N protein in PGJ2-treated cells might be due to an alteration of the glycosylation process.
The inability of Sendai virus to synthesize an active H N protein in the presence of PGJE was also shown by the lack of incorporation of H N into the cell m e m b r a n e , which can be easily determined because of the haemadsorbing property of this protein. Twenty-four h after Sendai virus infection, PGJE treatment caused a 86.1~o inhibition in haemadsorption by infected AGMK cells (control, 101.0 _+ 4.5; PGJ2, 14 .0 _+ 1.6 ~tg Hb/2 x 105 cells; P < 0-01).
The possibility that PGJ2 could be causing the production of defective virus particles devoid of HN was examined. AGMK monolayers infected with Sendai virus (10 HAU/105 cells) were treated with PGJ2 (4 ~tg/ml) starting after the 1 h adsorption period and were labelled with [35S]methionine (10 ~tCi/106 cells). Culture medium was harvested 48 h p.i. and, after centrifugation, supernatant proteins were precipitated with ammonium sulphate (280 txg/ml) overnight at 4 °C, in the presence of 1 mM-EDTA, 0-8 mM-N-ethylmaleimide and 0.2 mM-PMSF as proteinase inhibitors, as described by Alitalo et al. (1981) . Precipitates were collected by centrifugation, washed twice with 70~o ethanol, analysed by SDS-PAGE and processed for autoradiography and densitometric analysis. PGJ2 treatment was found to reduce the secretion of [35S]methionine-labelled proteins dramatically (control, 28.17 x 104; PGJ2, 3.04 × 104 c.p.m./106 cells), and to prevent the appearance of virus proteins in the supernatant (data not shown).
PGJ2 antiviral activity does not seem to be limited to this system. In fact preliminary data have also shown that PGJ 2 can inhibit the multiplication of a strain of herpes simplex virus type 2 isolated in our laboratory.
PGJ2 appears to act very similarly to prostaglandins of the A series, both in the active dose range and in the mechanism of action of their antiviral activity. PGA 1 has in fact been shown to produce similar alterations in the synthesis of the HN protein in this system (unpublished results) and of the virus G glycoprotein in L cells infected with vesicular stomatitis virus (Santoro et al., 1983) . PGA1 has also been shown to induce the synthesis of a polypeptide of the same mol. wt. as that induced by PGJ2 in AGMK cells (Santoro et al., 1982b) .
Both PGAs and PGJ2 contain an c~,fl-unsaturated carbonyl group in their cyclopentane ring, and this may be necessary for the antiviral activity. Interestingly, PGs of the A and D series, as well as PGJ2, have also been shown to possess a potent antiproliferative activity in several tumour models (Fukushima et al., 1982a,b; Honn et al., 1981 ; Santoro et al., 1986) , and this activity has also been related to the presence of a reactive c~,fl-unsaturated carbonyl group in the cyclopentane ring of the molecule (Honn & Marnett, 1985) .
Aside from the potential chemotherapeutic importance of these compounds, it is of great interest that the antiviral and antineoplastic activity of PGAs and PGJ 2 could be interrelated, or could be mediated by similar mechanisms.
